Clariant Valuation

Is CLNz undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLNz when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLNz (CHF14.42) is trading above our estimate of fair value (CHF9.69)

Significantly Below Fair Value: CLNz is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLNz?

Other financial metrics that can be useful for relative valuation.

CLNz key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.3x
Enterprise Value/EBITDA9.6x
PEG Ratio1.3x

Price to Earnings Ratio vs Peers

How does CLNz's PE Ratio compare to its peers?

The above table shows the PE ratio for CLNz vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average33.3x
JMAT Johnson Matthey
19.1x20.8%UK£3.4b
CRDA Croda International
38.4x15.2%UK£6.6b
VCT Victrex
36.9x32.8%UK£1.1b
ELM Elementis
39x28.6%UK£864.8m
CLNz Clariant
28.2x22.4%CHF4.7b

Price-To-Earnings vs Peers: CLNz is good value based on its Price-To-Earnings Ratio (28.2x) compared to the peer average (33.3x).


Price to Earnings Ratio vs Industry

How does CLNz's PE Ratio compare vs other companies in the GB Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: CLNz is expensive based on its Price-To-Earnings Ratio (28.2x) compared to the European Chemicals industry average (19.5x).


Price to Earnings Ratio vs Fair Ratio

What is CLNz's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLNz PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28.2x
Fair PE Ratio21.6x

Price-To-Earnings vs Fair Ratio: CLNz is expensive based on its Price-To-Earnings Ratio (28.2x) compared to the estimated Fair Price-To-Earnings Ratio (21.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLNz forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF14.42
CHF15.04
+4.3%
12.3%CHF20.00CHF11.50n/a14
May ’25CHF13.86
CHF15.04
+8.5%
12.3%CHF20.00CHF11.50n/a14
Apr ’25CHF12.17
CHF15.04
+23.6%
12.3%CHF20.00CHF11.50n/a14
Mar ’25CHF11.29
CHF15.04
+33.2%
12.3%CHF20.00CHF11.50n/a14
Feb ’25CHF11.09
CHF15.04
+35.6%
12.3%CHF20.00CHF11.50n/a14
Jan ’25CHF12.41
CHF15.47
+24.7%
11.3%CHF20.00CHF13.00n/a14
Dec ’24CHF12.98
CHF16.11
+24.1%
13.9%CHF22.00CHF13.90n/a15
Nov ’24CHF12.93
CHF16.11
+24.6%
13.9%CHF22.00CHF13.90n/a15
Oct ’24CHF14.56
CHF16.27
+11.8%
13.2%CHF22.00CHF14.00n/a15
Sep ’24CHF15.29
CHF16.44
+7.5%
14.6%CHF22.00CHF14.00n/a16
Aug ’24CHF14.27
CHF16.44
+15.2%
14.3%CHF22.00CHF14.00n/a16
Jul ’24CHF12.94
CHF17.97
+38.9%
14.4%CHF24.00CHF15.00n/a17
Jun ’24CHF13.24
CHF18.28
+38.0%
13.6%CHF24.00CHF15.00n/a16
May ’24CHF14.90
CHF18.67
+25.3%
12.1%CHF24.00CHF16.00CHF13.8616
Apr ’24CHF15.16
CHF18.84
+24.3%
11.4%CHF24.00CHF16.00CHF12.1716
Mar ’24CHF15.36
CHF18.88
+22.9%
11.1%CHF24.00CHF16.00CHF11.2917
Feb ’24CHF15.87
CHF18.96
+19.5%
10.7%CHF24.00CHF16.00CHF11.0917
Jan ’24CHF14.69
CHF19.08
+29.9%
10.5%CHF24.00CHF16.00CHF12.4117
Dec ’23CHF15.11
CHF19.17
+26.9%
10.4%CHF24.00CHF16.00CHF12.9817
Nov ’23CHF15.78
CHF19.32
+22.4%
10.3%CHF24.00CHF16.00CHF12.9317
Oct ’23CHF15.83
CHF20.25
+27.9%
12.4%CHF25.00CHF16.00CHF14.5617
Sep ’23CHF17.63
CHF19.95
+13.1%
12.7%CHF25.00CHF16.00CHF15.2917
Aug ’23CHF17.71
CHF19.95
+12.6%
12.7%CHF25.00CHF16.00CHF14.2717
Jul ’23CHF17.67
CHF20.63
+16.7%
10.0%CHF25.00CHF18.00CHF12.9417
Jun ’23CHF18.19
CHF20.51
+12.7%
10.0%CHF25.00CHF18.00CHF13.2417
May ’23CHF16.73
CHF20.39
+21.9%
10.9%CHF25.00CHF17.00CHF14.9017

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.